Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats

Yonsei Medical Journal

Volumn 46, Issue 1, 2005, Pages 141-148

  Kim, Beom Seok ^a   Park, Hyeong Cheon ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a   Ha, Sung Kyu ^a   Han, Dae Suk ^a   Lee, Ho Yung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cyclosporin; Nephrotic syndrome; PAN nephrosis; ZO 1

Indexed keywords

CREATININE; CYCLOSPORIN A; PROTEIN ZO1; PUROMYCIN AMINONUCLEOSIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG CLEARANCE; DRUG INHIBITION; GLOMERULUS; IMMUNOHISTOCHEMISTRY; MALE; NEPHROSIS; NONHUMAN; PODOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RAT STRAIN; SINGLE DRUG DOSE; WESTERN BLOTTING;

EID: 14944375866     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.1.141     Document Type: Article

References (44)

1. Caulfield JP, Farquhar MG. The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier. J Cell Biol 1974;63:883-903.
2. Farquhar MG, Vernier RL, Good RA. Studies on familial nephrosis. II. Glomerular changes observed with the electron microscope. Am J Pathol 1957;33:791-817.
3. Kerjaschki D. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001;108:1583-7.
4. Kanwar YS, Liu ZZ, Kashihara N, Wallner EI. Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 1991;11:390-413.
5. Farquhar MG. Editorial: The primary glomerular filtration barrier - basement membrane or epithelial slits? Kidney Int 1975;8:197-211.
6. Rodewald R, Karnovsky MJ. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol 1974;60:423-33.
7. Graham RC, Jr., Karnovsky MJ. Glomerular permeability. Ultrastructural cytochemical studies using peroxidases as protein tracers. J Exp Med 1966;124:1123-34.
8. Daniels BS, Deen WM, Mayer G, Meyer T, Hostetter TH. Glomerular permeability barrier in the rat. Functional assessment by in vitro methods. J Clin Invest 1993;92:929-36.
9. Orikasa M, Matsui K, Oite T, Shimizu F. Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol 1988; 141:807-14.
10. Kawachi H, Kurihara H, Topham PS, Brown D, Shia MA, Orikasa M, et al. Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am J Physiol 1997;273(6 Pt 2):F984-93.
11. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003;83:253-307.
12. Smithies O. Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function. Proc Natl Acad Sci USA 2003;100:4108-13.
13. Schnabel E, Anderson JM, Farquhar MG. The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J Cell Biol 1990;111:1255-63.
14. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575-82.
15. Reiser J, Kriz W, Kretzler M, Mundel P. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000;11:1-8.
16. Inoue T, Yaoita E, Kurihara H, Shimizu F, Sakai T, Kobayashi T, et al. FAT is a component of glomerular slit diaphragms. Kidney Int 2001;59:1003-12.
17. Macconi D, Ghilardi M, Bonassi ME, Mohamed EI, Abbate M, Colombi F, et al. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 2000;11: 477-89.
18. Kurihara H, Anderson JM, Kerjaschki D, Farquhar MG. The altered glomerular filtration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1. Am J Pathol 1992;141:805-16.
19. Lieberman KV, Tejani A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 1996;7:56-63.
20. Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, et al. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. J Am Soc Nephrol 1996;7:543-9.
21. Meyrier A, Noel LH, Auriche P, Callard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int 1994;45:1446-56.
22. Meyrier A. Antiproteinuric and immunological effects of cyclosporin A in the treatment of glomerular diseases. Nephrol Dial Transplant 1992;7 Suppl 1:80-4.
23. Jameson MD SV, Sharma R, Lovell HB, Diederich DA. Cyclosporine treatment decreases glomerular ultrafiltration coefficient. In: Proc Natl Kidney Found 19th Annu Sci Meet; 1989; Washington; 1989. p. Abstract A12.
24. Zietse R, Wenting GJ, Kramer P, Schalekamp MA, Weimar W. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci (Lond) 1992;82:641-50.
25. Kokui K, Yoshikawa N, Nakamura H, Itoh H. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis. J Pathol 1992;166:297-301.
26. Luimula P, Sandstrom N, Novikov D, Holthofer H. Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 2002;82:713-8.
27. Comper WD, Glasgow EF. Charge selectivity in kidney ultrafiltration. Kidney Int 1995;47:1242-51.
28. Goode NP, Shires M, Davison AM. The glomerular basement membrane charge-selectivity barrier: an oversimplified concept? Nephrol Dial Transplant 1996; 11:1714-6.
29. Bridges CR, Myers BD, Brenner BM, Deen WM. Glomerular charge alterations in human minimal change nephropathy. Kidney Int 1982;22:677-84.
30. Caulfield JP, Reid JJ, Farquhar MG. Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment. Lab Invest 1976;34:43-59.
31. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am J Pathol 1986;122: 481-7.
32. Venkatachalam MA, Cotran RS, Karnovsky MJ. An ultrastructural study of glomerular permeability in aminonucleoside nephrosis using catalase as a tracer protein. J Exp Med 1970;132:1168-80.
33. Ryan GB, Karnovsky MJ. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 1975;8:219-32.
34. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I, et al. Nephrin in experimental glomerular disease. Kidney Int 2000;58:1461-8.
35. Brodehl J, Brandis M, Helmchen U, Hoyer PF, Burghard R, Ehrich JH, et al. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Klin Wochenschr 1988;66:1126-37.
36. Meyrier A, Simon P, Perret G, Condamin-Meyrier MC. Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. Br Med J (Clin Res Ed) 1986; 292:789-92.
37. Tejani AT, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988;33:729-34.
38. Tejani A, Ingulli E. Cyclosporin in steroid-resistant idiopathic nephrotic syndrome. Contrib Nephrol 1995; 114:73-7.
39. Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int 2002;62:2301-10.
40. Bustos C, Gonzalez-Cuadrado S, Ruiz-Ortega M, Gomez-Guerrero C, Gonzalez E, Plaza JJ, et al. Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis. Clin Exp Immunol 1995;102:608-13.
41. Wang JS, Yang AH, Chen SM, Young TK, Chiang H, Liu HC. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis. Nephron 1993;65:418-25.
42. Meyrier A. Treatment of glomerular disease with cyclosporin A. Nephrol Dial Transplant 1989;4:923-31.
43. Chen D, Jefferson B, Harvey SJ, Zheng K, Gartley CJ, Jacobs RM, et al. Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model. J Am Soc Nephrol 2003;14:690-8.
44. Berden JHM, Assmann KJM, Koene RAP. Antiproteinuric effect of cyclosporin (CsA) in anti-GBM nephritis in the mouse. J Autoimmun 1992;5 Suppl A:185.